Efficacy and safety of pembrolizumab/carrelizumab, alone or in combination with chemotherapy in treatment of patients with non-small cell lung cancer: A protocol for evidence-based systematic review and Bayesian network meta-analysis

BACKGROUND: To date, there have been no reported trials that directly compare pembrolizumab/carrelizumab monotherapy versus pembrolizumab/carrelizumab and chemotherapy in the first-line treatment setting of advanced/metastatic non-small cell lung cancer (NSCLC). We performed a Bayesian network meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaofei, Qian, Hui, Qu, Xiangkun, Jiang, Yalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294917/
https://www.ncbi.nlm.nih.gov/pubmed/34398032
http://dx.doi.org/10.1097/MD.0000000000026672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294917/
https://www.ncbi.nlm.nih.gov/pubmed/34398032
http://dx.doi.org/10.1097/MD.0000000000026672

Ejemplares similares